Published in Kidney Int on August 08, 2007
Vitamin D deficiency and risk of cardiovascular disease. Circulation (2008) 13.39
25-hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med (2008) 9.50
Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. N Engl J Med (2008) 9.19
Phosphorus binders and survival on hemodialysis. J Am Soc Nephrol (2008) 3.26
Impact of activated vitamin D and race on survival among hemodialysis patients. J Am Soc Nephrol (2008) 2.96
25-hydroxyvitamin D levels inversely associate with risk for developing coronary artery calcification. J Am Soc Nephrol (2009) 2.87
Bioavailable vitamin D is more tightly linked to mineral metabolism than total vitamin D in incident hemodialysis patients. Kidney Int (2012) 2.74
Diuretics, calciuria and secondary hyperparathyroidism in the Chronic Renal Insufficiency Cohort. Nephrol Dial Transplant (2011) 2.60
Chronic kidney disease, hypovitaminosis D, and mortality in the United States. Kidney Int (2009) 2.52
Predicting six-month mortality for patients who are on maintenance hemodialysis. Clin J Am Soc Nephrol (2009) 2.38
The FGF23-Klotho axis: endocrine regulation of phosphate homeostasis. Nat Rev Endocrinol (2009) 2.26
Activated vitamin D attenuates left ventricular abnormalities induced by dietary sodium in Dahl salt-sensitive animals. Proc Natl Acad Sci U S A (2007) 2.25
Estimated GFR and circulating 24,25-dihydroxyvitamin D3 concentration: a participant-level analysis of 5 cohort studies and clinical trials. Am J Kidney Dis (2014) 2.23
Vitamin D and risk of future hypertension: meta-analysis of 283,537 participants. Eur J Epidemiol (2013) 1.87
Update on fibroblast growth factor 23 in chronic kidney disease. Kidney Int (2012) 1.82
Vitamin D deficiency is associated with sudden cardiac death, combined cardiovascular events, and mortality in haemodialysis patients. Eur Heart J (2010) 1.72
Vitamin D reduces the expression of collagen and key profibrotic factors by inducing an antifibrotic phenotype in mesenchymal multipotent cells. J Endocrinol (2008) 1.72
Genetic variation in APOL1 associates with younger age at hemodialysis initiation. J Am Soc Nephrol (2011) 1.70
The vitamin D deficiency pandemic and consequences for nonskeletal health: mechanisms of action. Mol Aspects Med (2008) 1.69
Vitamin D supplementation in chronic kidney disease: a systematic review and meta-analysis of observational studies and randomized controlled trials. Clin J Am Soc Nephrol (2010) 1.63
FGF-23: More than a regulator of renal phosphate handling? J Bone Miner Res (2010) 1.63
Vitamin D deficiency and risk for cardiovascular disease. Am J Med Sci (2009) 1.62
Postprandial mineral metabolism and secondary hyperparathyroidism in early CKD. J Am Soc Nephrol (2008) 1.60
Effects of cholecalciferol on functional, biochemical, vascular, and quality of life outcomes in hemodialysis patients. Clin J Am Soc Nephrol (2013) 1.60
Possible renoprotection by vitamin D in chronic renal disease: beyond mineral metabolism. Nat Rev Nephrol (2009) 1.51
Inverse relationship between long-chain n-3 fatty acids and risk of sudden cardiac death in patients starting hemodialysis. Kidney Int (2013) 1.48
Paricalcitol versus cinacalcet plus low-dose vitamin D for the treatment of secondary hyperparathyroidism in patients receiving haemodialysis: study design and baseline characteristics of the IMPACT SHPT study. Nephrol Dial Transplant (2011) 1.46
Race, Mineral Homeostasis and Mortality in Patients with End-Stage Renal Disease on Dialysis. Am J Nephrol (2015) 1.46
Low 25-hydroxyvitamin D levels and cognitive impairment in hemodialysis patients. Clin J Am Soc Nephrol (2013) 1.44
Cross talk between the renin-angiotensin-aldosterone system and vitamin D-FGF-23-klotho in chronic kidney disease. J Am Soc Nephrol (2011) 1.42
Parathyroidectomy improves survival in patients with severe hyperparathyroidism: a comparative study. PLoS One (2013) 1.39
Nutritional vitamin D supplementation and health-related outcomes in hemodialysis patients: a protocol for a systematic review and meta-analysis. Syst Rev (2015) 1.38
Cardiovascular risk in the peritoneal dialysis patient. Nat Rev Nephrol (2010) 1.31
Vitamins K and D status in stages 3-5 chronic kidney disease. Clin J Am Soc Nephrol (2010) 1.31
Vascular calcification: an update on mechanisms and challenges in treatment. Calcif Tissue Int (2013) 1.29
Vitamin D levels, microvascular complications, and mortality in type 1 diabetes. Diabetes Care (2011) 1.28
Vitamin D affects survival independently of vascular calcification in chronic kidney disease. Clin J Am Soc Nephrol (2009) 1.26
Clinical measures identify vitamin D deficiency in dialysis. Clin J Am Soc Nephrol (2010) 1.25
Vitamin D levels and mortality in type 2 diabetes. Diabetes Care (2010) 1.21
Fibroblast growth factor-23 in early chronic kidney disease: additional support in favor of a phosphate-centric paradigm for the pathogenesis of secondary hyperparathyroidism. Clin J Am Soc Nephrol (2010) 1.21
Outcome predictability of serum alkaline phosphatase in men with pre-dialysis CKD. Nephrol Dial Transplant (2010) 1.19
Vitamin D insufficiency: implications for the immune system. Pediatr Nephrol (2010) 1.18
Active vitamin D treatment for reduction of residual proteinuria: a systematic review. J Am Soc Nephrol (2013) 1.17
Vitamin D and kidney disease. Clin J Am Soc Nephrol (2008) 1.16
Plasma gelsolin and circulating actin correlate with hemodialysis mortality. J Am Soc Nephrol (2009) 1.16
Vitamin D deficiency, self-reported physical activity and health-related quality of life: the Comprehensive Dialysis Study. Nephrol Dial Transplant (2011) 1.15
Association of serum 25-hydroxyvitamin D with the risk of death in a general older population in Finland. Eur J Nutr (2010) 1.14
Potential for vitamin D receptor agonists in the treatment of cardiovascular disease. Br J Pharmacol (2009) 1.13
Vitamin D therapy in chronic kidney disease and end stage renal disease. Clin J Am Soc Nephrol (2011) 1.09
Associations of plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D concentrations with death and progression to maintenance dialysis in patients with advanced kidney disease. Am J Kidney Dis (2012) 1.05
Vitamin D and diabetes: let the sunshine in. Diabetes Educ (2008) 1.05
The noncalciotropic actions of vitamin D: recent clinical developments. Curr Opin Nephrol Hypertens (2008) 1.04
Racial differences in markers of mineral metabolism in advanced chronic kidney disease. Clin J Am Soc Nephrol (2012) 1.03
FGF-23 and PTH levels in patients with acute kidney injury: A cross-sectional case series study. Ann Intensive Care (2011) 1.02
Klotho variants and chronic hemodialysis mortality. J Bone Miner Res (2009) 1.02
Effect of paricalcitol on left ventricular mass and function in CKD--the OPERA trial. J Am Soc Nephrol (2013) 1.02
Vitamin D deficiency and toxicity in chronic kidney disease: in search of the therapeutic window. Pediatr Nephrol (2010) 1.00
Paricalcitol does not improve glucose metabolism in patients with stage 3-4 chronic kidney disease. Kidney Int (2012) 0.99
Paricalcitol versus cinacalcet plus low-dose vitamin D therapy for the treatment of secondary hyperparathyroidism in patients receiving haemodialysis: results of the IMPACT SHPT study. Nephrol Dial Transplant (2012) 0.99
Vitamin D and glucose metabolism in chronic kidney disease. Curr Opin Nephrol Hypertens (2008) 0.97
25-hydroxyvitamin D concentration is inversely associated with serum MMP-9 in a cross-sectional study of African American ESRD patients. BMC Nephrol (2011) 0.96
Alkaline phosphatase and mortality in patients on peritoneal dialysis. Clin J Am Soc Nephrol (2014) 0.95
Reduced hepatic synthesis of calcidiol in uremia. J Am Soc Nephrol (2010) 0.95
Nutritional vitamin D supplementation in dialysis: a randomized trial. Clin J Am Soc Nephrol (2015) 0.94
Efficacy and safety of a short course of very-high-dose cholecalciferol in hemodialysis. Am J Clin Nutr (2012) 0.94
The effect of vitamin D status on risk factors for cardiovascular disease. Nat Rev Nephrol (2013) 0.92
Diseases of the parathyroid gland in chronic kidney disease. Clin Exp Nephrol (2011) 0.92
Vitamin D and cardiovascular disease: potential role in health disparities. J Health Care Poor Underserved (2011) 0.92
Soluble erythropoietin receptor contributes to erythropoietin resistance in end-stage renal disease. PLoS One (2010) 0.92
Baseline characteristics of an incident haemodialysis population in Spain: results from ANSWER--a multicentre, prospective, observational cohort study. Nephrol Dial Transplant (2008) 0.90
Ergocalciferol decreases erythropoietin resistance in children with chronic kidney disease stage 5. Pediatr Nephrol (2013) 0.90
Low Vitamin D and High Fibroblast Growth Factor 23 Serum Levels Associate with Infectious and Cardiac Deaths in the HEMO Study. J Am Soc Nephrol (2015) 0.90
The virtues of vitamin D--but how much is too much? Pediatr Nephrol (2010) 0.90
Can vitamin D slow down the progression of chronic kidney disease? Pediatr Nephrol (2011) 0.90
Fibroblast growth factor-23: what we know, what we don't know, and what we need to know. Nephrol Dial Transplant (2013) 0.89
The role of vitamin D in blood pressure, endothelial and renal function in postmenopausal women. Nutrients (2013) 0.89
Low Dietary Intake of Vitamin D and Vitamin D Deficiency in Hemodialysis Patients. J Nephrol Ther (2014) 0.88
Vascular calcification and renal bone disorders. ScientificWorldJournal (2014) 0.88
Determination and validation of aortic calcification measurement from lateral bone densitometry in dialysis patients. Clin J Am Soc Nephrol (2008) 0.87
Extra-skeletal effects of vitamin D deficiency in chronic kidney disease. Ann Med (2011) 0.87
Vitamin D levels are associated with cardiac autonomic activity in healthy humans. Nutrients (2013) 0.87
Left Ventricular Hypertrophy in Chronic Kidney Disease Patients: From Pathophysiology to Treatment. Cardiorenal Med (2015) 0.87
The role of 25-hydroxyvitamin D deficiency in promoting insulin resistance and inflammation in patients with chronic kidney disease: a randomised controlled trial. BMC Nephrol (2009) 0.87
Vitamin D insufficiency and deficiency with stages of chronic kidney disease in an Asian population. BMC Nephrol (2013) 0.87
The immunoregulatory function of vitamin D: implications in chronic kidney disease. Nat Rev Nephrol (2012) 0.87
Clinical Significance of FGF-23 in Patients with CKD. Int J Nephrol (2011) 0.86
A prospective study of serum 25-hydroxyvitamin d levels and mortality among African Americans and non-African Americans. Am J Epidemiol (2012) 0.86
25-Hydroxyvitamin D levels and chronic kidney disease in the AusDiab (Australian Diabetes, Obesity and Lifestyle) study. BMC Nephrol (2012) 0.86
Cardiorespiratory fitness is independently associated with 25-hydroxyvitamin D in chronic kidney disease. Clin J Am Soc Nephrol (2010) 0.86
Uraemic vasculopathy in children with chronic kidney disease: prevention or damage limitation? Pediatr Nephrol (2010) 0.85
Vitamin D levels and their relationship with cardiac biomarkers in chronic hemodialysis patients. J Korean Med Sci (2009) 0.85
25-OH-vitamin D deficiency and cellular alloimmunity as measured by panel of reactive T cell testing in dialysis patients. Am J Transplant (2010) 0.85
Role of vitamin D in diabetes mellitus and chronic kidney disease. World J Diabetes (2016) 0.84
The impact of pretransplant 25-hydroxy vitamin D deficiency on subsequent graft function: an observational study. BMC Nephrol (2012) 0.84
Vitamin D deficiency does not predict progression of coronary artery calcium, carotid intima-media thickness or high-sensitivity C-reactive protein in systemic lupus erythematosus. Rheumatology (Oxford) (2013) 0.84
Evaluation of hypophosphatemia: lessons from patients with genetic disorders. Am J Kidney Dis (2011) 0.83
Diagnosis and management of mineral metabolism in CKD. J Gen Intern Med (2010) 0.83
Prevalence and prognostic implications of vitamin D deficiency in chronic kidney disease. Dis Markers (2015) 0.82
The influence of vitamin D analogs on calcification modulators, N-terminal pro-B-type natriuretic peptide and inflammatory markers in hemodialysis patients: a randomized crossover study. BMC Nephrol (2014) 0.82
Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med (1991) 23.89
Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med (1995) 21.16
Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). Proc Natl Acad Sci U S A (1996) 12.89
Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and without HIV infection. N Engl J Med (1995) 8.52
Kaposi's sarcoma. N Engl J Med (2000) 6.81
Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV. Science (1996) 6.57
KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma. Nat Med (1996) 5.96
Primary characterization of a herpesvirus agent associated with Kaposi's sarcomae. J Virol (1996) 5.05
Risk of overweight among adolescents who were breastfed as infants. JAMA (2001) 4.80
Transcription mapping of the Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) genome in a body cavity-based lymphoma cell line (BC-1). J Virol (1998) 4.62
Ten-year experience with 733 pancreatic resections: changing indications, older patients, and decreasing length of hospitalization. Arch Surg (2001) 4.59
Effect of economic reforms on child growth in urban and rural areas of China. N Engl J Med (1996) 4.50
Selective switch between latency and lytic replication of Kaposi's sarcoma herpesvirus and Epstein-Barr virus in dually infected body cavity lymphoma cells. J Virol (1997) 4.45
Definition and classification of negative outcomes in solid organ transplantation. Application in liver transplantation. Ann Surg (1994) 4.24
Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma. N Engl J Med (1996) 4.13
Relationship between Helicobacter pylori iceA, cagA, and vacA status and clinical outcome: studies in four different countries. J Clin Microbiol (1999) 4.13
The effect of enforcing tobacco-sales laws on adolescents' access to tobacco and smoking behavior. N Engl J Med (1997) 4.06
BRCA1 dysfunction in sporadic basal-like breast cancer. Oncogene (2006) 3.91
Angiogenic and HIV-inhibitory functions of KSHV-encoded chemokines. Science (1997) 3.70
Family dinner and diet quality among older children and adolescents. Arch Fam Med (2000) 3.64
Progression of kidney dysfunction in the community-dwelling elderly. Kidney Int (2006) 3.64
Antibodies to butyrate-inducible antigens of Kaposi's sarcoma-associated herpesvirus in patients with HIV-1 infection. N Engl J Med (1996) 3.61
Kaposi's sarcoma-associated herpesvirus contains G protein-coupled receptor and cyclin D homologs which are expressed in Kaposi's sarcoma and malignant lymphoma. J Virol (1996) 3.48
Cyclin encoded by KS herpesvirus. Nature (1996) 3.32
Bacteraemia and antibiotic resistance of its pathogens reported in England and Wales between 1990 and 1998: trend analysis. BMJ (2000) 3.10
An islet of ability in autistic children: a research note. J Child Psychol Psychiatry (1983) 3.10
Activity, dietary intake, and weight changes in a longitudinal study of preadolescent and adolescent boys and girls. Pediatrics (2000) 2.96
Vibrio cholerae hemagglutinin/protease, colonial variation, virulence, and detachment. Infect Immun (1992) 2.80
Impaired host defense, hematopoiesis, granulomatous inflammation and type 1-type 2 cytokine balance in mice lacking CC chemokine receptor 1. J Exp Med (1997) 2.79
Role of NADH/NADPH oxidase-derived H2O2 in angiotensin II-induced vascular hypertrophy. Hypertension (1998) 2.70
Delayed posthypoxic demyelination. Association with arylsulfatase A deficiency and lactic acidosis on proton MR spectroscopy. Neurology (1997) 2.66
Angiogenesis and hematopoiesis induced by Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6. Blood (1999) 2.65
Toward an optimal algorithm for ovarian cancer screening with longitudinal tumor markers. Cancer (1995) 2.64
Kaposi's sarcoma-associated herpesvirus encodes a functional bcl-2 homologue. Nat Med (1997) 2.64
Caspase inhibitor affords neuroprotection with delayed administration in a rat model of neonatal hypoxic-ischemic brain injury. J Clin Invest (1998) 2.64
KSHV ORF K9 (vIRF) is an oncogene which inhibits the interferon signaling pathway. Oncogene (1997) 2.57
Idiopathic hypertrophic pachymeningitis. Neurology (2004) 2.55
Differential viral protein expression in Kaposi's sarcoma-associated herpesvirus-infected diseases: Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease. Am J Pathol (2000) 2.55
Processes of care, illness severity, and outcomes in the management of community-acquired pneumonia at academic hospitals. Arch Intern Med (2001) 2.51
Kaposi's sarcoma-associated herpesvirus infection prior to onset of Kaposi's sarcoma. AIDS (1996) 2.49
Relationship between the cagA 3' repeat region of Helicobacter pylori, gastric histology, and susceptibility to low pH. Gastroenterology (1999) 2.44
Characterization and cell cycle regulation of the major Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) latent genes and their promoter. J Virol (1999) 2.41
Peer, parent, and media influences on the development of weight concerns and frequent dieting among preadolescent and adolescent girls and boys. Pediatrics (2001) 2.40
Effect of postoperative complications on health and employment following liver transplantation. Clin Transplant (1998) 2.40
Basal-like breast carcinomas: clinical outcome and response to chemotherapy. J Clin Pathol (2006) 2.40
Association of genetic variation in FTO with risk of obesity and type 2 diabetes with data from 96,551 East and South Asians. Diabetologia (2011) 2.37
Overweight, weight concerns, and bulimic behaviors among girls and boys. J Am Acad Child Adolesc Psychiatry (1999) 2.33
Leaving gatekeeping behind--effects of opening access to specialists for adults in a health maintenance organization. N Engl J Med (2001) 2.29
Variation in institutional review board responses to a standard protocol for a multicenter clinical trial. Acad Emerg Med (2001) 2.28
Infliximab for refractory ulcerative colitis. Am J Gastroenterol (2001) 2.26
The cyclin encoded by Kaposi's sarcoma-associated herpesvirus stimulates cdk6 to phosphorylate the retinoblastoma protein and histone H1. J Virol (1997) 2.24
Helicobacter pylori infection in intestinal- and diffuse-type gastric adenocarcinomas. J Natl Cancer Inst (1991) 2.23
Prevalence of Asperger's syndrome in a secure hospital. Br J Psychiatry (1994) 2.23
Protruding aortic arch atheromas: risk of stroke during heart surgery with and without aortic arch endarterectomy. Am Heart J (1999) 2.21
Kaposi's sarcoma-associated herpesvirus LANA2 is a B-cell-specific latent viral protein that inhibits p53. J Virol (2001) 2.21
Surgical and nonsurgical management of sciatica secondary to a lumbar disc herniation: five-year outcomes from the Maine Lumbar Spine Study. Spine (Phila Pa 1976) (2001) 2.17
Catatonia in autistic spectrum disorders. Br J Psychiatry (2000) 2.15
Implications of stroke risk criteria on the anticoagulation decision in nonvalvular atrial fibrillation: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study. Circulation (2000) 2.09
Multiple metal contamination from house paints: consequences of power sanding and paint scraping in New Orleans. Environ Health Perspect (2001) 2.07
Socioeconomic inequalities in cancer survival in England after the NHS cancer plan. Br J Cancer (2010) 2.07
Allergic bronchopulmonary aspergillosis: review of literature and proposal of new diagnostic and classification criteria. Clin Exp Allergy (2013) 2.03
The impact of choice of muscle relaxant on postoperative recovery time: a retrospective study. Anesth Analg (1997) 2.03
Public health. The cholera crisis in Africa. Science (2009) 2.02
Inhaled tiotropium for stable chronic obstructive pulmonary disease. Cochrane Database Syst Rev (2005) 2.00
A Kaposi's sarcoma-associated herpesvirus-encoded cytokine homolog (vIL-6) activates signaling through the shared gp130 receptor subunit. J Biol Chem (1997) 2.00
Molecular epidemiology of Helicobacter pylori: separation of H. pylori from East Asian and non-Asian countries. Epidemiol Infect (2000) 1.97
Distinct roles for the p110alpha and hVPS34 phosphatidylinositol 3'-kinases in vesicular trafficking, regulation of the actin cytoskeleton, and mitogenesis. J Cell Biol (1998) 1.97
Long-term disability and return to work among patients who have a herniated lumbar disc: the effect of disability compensation. J Bone Joint Surg Am (2000) 1.95
Establishing a KSHV+ cell line (BCP-1) from peripheral blood and characterizing its growth in Nod/SCID mice. Blood (1998) 1.95
Lymphangiomatosis. Histologic and immunohistochemical analysis of four cases. Am J Surg Pathol (1993) 1.84
MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo. Oncogene (2011) 1.81
Metaplastic breast carcinomas are basal-like tumours. Histopathology (2006) 1.80
Prevention of heterosexual transmission of human immunodeficiency virus through couple counseling. J Acquir Immune Defic Syndr (1993) 1.79
Tiotropium for stable chronic obstructive pulmonary disease: A meta-analysis. Thorax (2006) 1.76
Outcome of pancreaticoduodenectomy with pylorus preservation or with antrectomy in the treatment of chronic pancreatitis. Ann Surg (2000) 1.76
Results of hepatic resection for sarcoma metastatic to liver. Ann Surg (2001) 1.75
Expression of a virus-derived cytokine, KSHV vIL-6, in HIV-seronegative Castleman's disease. Am J Pathol (1997) 1.72
Short-acting nifedipine and risk of stroke in elderly hypertensive patients. Neurology (2011) 1.70
Eating disorders in males: a report on 135 patients. Am J Psychiatry (1997) 1.70
Allosteric effects of permeating cations on gating currents during K+ channel deactivation. J Gen Physiol (1997) 1.70
Recurrent pyogenic cholangitis. Am J Surg (1998) 1.69
Bariatric surgery: a systematic review and network meta-analysis of randomized trials. Obes Rev (2011) 1.68
Spontaneous remission of primary hyperparathyroidism from parathyroid apoplexy. J Clin Endocrinol Metab (1996) 1.66
Molecular virology of Kaposi's sarcoma-associated herpesvirus. Philos Trans R Soc Lond B Biol Sci (2001) 1.65
Antitumor activity of sorafenib in FLT3-driven leukemic cells. Leukemia (2007) 1.65
Fluorides for the prevention of white spots on teeth during fixed brace treatment. Cochrane Database Syst Rev (2004) 1.64
Establishment of AIDS-related lymphoma cell lines from lymphomatous effusions. Leukemia (1996) 1.63
Helicobacter pylori outer membrane proteins and gastroduodenal disease. Gut (2005) 1.62
Smoking and tuberculosis: an association overlooked. Int J Tuberc Lung Dis (2002) 1.62
Is improvement possible in the measurement of behaviour disturbance in dementia? Int J Geriatr Psychiatry (1999) 1.61
Association between leptin and asthma in adults. Thorax (2006) 1.59
Test-retest reliability of a functional MRI working memory paradigm in normal and schizophrenic subjects. Am J Psychiatry (2001) 1.59
Epidemiology and prospects for prevention of rotavirus disease in India. Indian Pediatr (2012) 1.58
Validation of influenza and pneumococcal vaccine status in adults based on self-report. Epidemiol Infect (2006) 1.56